Sodium glucose co-transporter 2 inhibition: a new avenue to protect the kidney

av Heerspink, Hiddo J L
I publikationen Nephrol Dial Transplant (2019)

Trial Design Innovations to Accelerate Therapeutic Advances in Chronic Kidney Disease: Moving from Single Trials to an Ongoing Platform

av Heerspink, Hiddo J.L., Perkovic, Vlado
I publikationen Clin J Am Soc Nephrol (2018)

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease

av Heerspink, Hiddo J. L., De Zeeuw, Dick
I publikationen Diabetologia (2016)

Treating diabetic complications; from large randomized clinical trials to precision medicine

av Heerspink, Hiddo J. L., de Zeeuw, Dick
I publikationen Diabetes Obes Metab (2018)

Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathy

av de Zeeuw, Dick, Heerspink, Hiddo J L
I publikationen Nephrol Dial Transplant (2020)

New clinical trial designs for establishing drug efficacy and safety in a precision medicine era

av Heerspink, Hiddo J. L., List, James, Perkovic, Vlado
I publikationen Diabetes Obes Metab (2018)

Editorial: The role of sodium-glucose cotransporter 2 inhibitors in the management of chronic kidney disease

av Heerspink, Hiddo J L, Fouque, Denis, Wanner, Christoph
I publikationen Nephrol Dial Transplant (2020)

Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease

av Pena, Michelle J., Mischak, Harald, Heerspink, Hiddo J. L.
I publikationen Diabetologia (2016)

ACCORDION: Ensuring That We Hear the Music Clearly

av Wong, Muh Geot, Heerspink, Hiddo J.L., Perkovic, Vlado
I publikationen Clin J Am Soc Nephrol (2018)

Exposure–response relationships of dapagliflozin on cardiorenal risk markers and adverse events: A pooled analysis of 13 phase II/III trials

av Koomen, Jeroen V., Stevens, Jasper, Heerspink, Hiddo J.L.
I publikationen Br J Clin Pharmacol (2020)

Precision medicine approaches for diabetic kidney disease: opportunities and challenges

av Tye, Sok Cin, Denig, Petra, Heerspink, Hiddo J L
I publikationen Nephrol Dial Transplant (2021)

New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors

av Dekkers, Claire C. J., Gansevoort, Ron T., Heerspink, Hiddo J. L.
I publikationen Curr Diab Rep (2018)

Multimarker Panels in Diabetic Kidney Disease: The Way to Improved Clinical Trial Design and Clinical Practice?

av Perco, Paul, Pena, Michelle, Heerspink, Hiddo J.L., Mayer, Gert
I publikationen Kidney Int Rep (2018)

Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus

av Vinke, Joanna Sophia J., Heerspink, Hiddo J.L., de Borst, Martin H.
I publikationen Curr Opin Nephrol Hypertens (2019)

No significant association of type 2 diabetes‐related genetic risk scores with glycated haemoglobin levels after initiating metformin or sulphonylurea derivatives

av Martono, Doti P., Heerspink, Hiddo J.L., Hak, Eelko, Denig, Petra, Wilffert, Bob
I publikationen Diabetes Obes Metab (2019)

Blood pressure‐lowering effects of sulodexide depend on albuminuria severity: post hoc analysis of the sulodexide microalbuminuria and macroalbuminuria studies

av Olde Engberink, Rik H. G., Heerspink, Hiddo J. L., de Zeeuw, Dick, Vogt, Liffert
I publikationen Br J Clin Pharmacol (2016)

Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects

av Heerspink, Hiddo J. L., Desai, Mehul, Jardine, Meg, Balis, Dainius, Meininger, Gary, Perkovic, Vlado
I publikationen J Am Soc Nephrol (2017)

Is Chronic Dialysis the Right Hard Renal End Point To Evaluate Renoprotective Drug Effects?

av Weldegiorgis, Misghina, de Zeeuw, Dick, Dwyer, Jamie P., Mol, Peter, Heerspink, Hiddo J.L.
I publikationen Clin J Am Soc Nephrol (2017)

Precision medicine in diabetes and diabetic kidney disease: Regulatory considerations

av Mol, Peter G. M., Thompson, Aliza, Heerspink, Hiddo J. L., Leufkens, Hubert G. M.
I publikationen Diabetes Obes Metab (2018)

Association between individual cholesterol and proteinuria response and exposure to atorvastatin or rosuvastatin

av Kroonen, Marjolein Y. A. M., Stevens, Jasper, de Zeeuw, Dick, Heerspink, Hiddo J. L.
I publikationen Diabetes Obes Metab (2019)